Interleukin 21 blockade modulates activated T- and B-cell homeostasis via B-cell activating factor pathway–mediated inhibition in a murine model of acute graft-versus-host disease

Spolski, 2008, Interleukin-21: basic biology and implications for cancer and autoimmunity, Annu Rev Immunol, 26, 57, 10.1146/annurev.immunol.26.021607.090316 Jin, 2006, Redundant and unique regulation of activated mouse B lymphocytes by IL-4 and IL-21, J Leukoc Biol, 80, 1416, 10.1189/jlb.0206096 Konforte, 2009, IL-21: an executor of B cell fate, J Immunol, 182, 1781, 10.4049/jimmunol.0803009 Nojima, 2011, In-vitro derived germinal centre B cells differentially generate memory B or plasma cells in vivo, Nat Commun, 2, 465 Eto, 2011, IL-21 and IL-6 are critical for different aspects of B cell immunity and redundantly induce optimal follicular helper CD4 T cell (Tfh) differentiation, PLoS One, 6, e17739, 10.1371/journal.pone.0017739 Oh, 2010, Altered effector CD4+ T cell function in IL-21R-/- CD4+ T cell-mediated graft-versus-host disease, J Immunol, 185, 1920, 10.4049/jimmunol.0902217 Hanash, 2011, Abrogation of donor T-cell IL-21 signaling leads to tissue-specific modulation of immunity and separation of GVHD from GVL, Blood, 118, 446, 10.1182/blood-2010-07-294785 Bucher, 2009, IL-21 blockade reduces graft-versus-host disease mortality by supporting inducible T regulatory cell generation, Blood, 114, 5375, 10.1182/blood-2009-05-221135 Meguro, 2010, IL-21 is critical for GVHD in a mouse model, Bone Marrow Transplant, 45, 723, 10.1038/bmt.2009.223 Meguro, 2011, Lack of IL-21 signal attenuates graft-versus-leukemia effect in the absence of CD8 T-cells, Bone Marrow Transplant, 46, 1557, 10.1038/bmt.2010.342 Hippen, 2012, Blocking IL-21 signaling ameliorates xenogeneic GVHD induced by human lymphocytes, Blood, 119, 619, 10.1182/blood-2011-07-368027 Shimabukuro-Vornhagen, 2009, The role of B cells in the pathogenesis of graft-versus-host disease, Blood, 114, 4919, 10.1182/blood-2008-10-161638 Kim, 2012, B cell homeostasis and the development of chronic graft-versus-host disease: implications for B cell-depleting therapy, Leuk Lymphoma, 53, 19, 10.3109/10428194.2011.603448 Kharfan-Dabaja, 2011, Rituximab for prevention and treatment of graft-versus-host disease, Int J Hematol, 93, 578, 10.1007/s12185-011-0855-2 Dominietto, 2012, In vivo B-cell depletion with rituximab for alternative donor hemopoietic SCT, Bone Marrow Transplant, 47, 101, 10.1038/bmt.2011.28 Alousi, 2010, The role of B cell depleting therapy in graft versus host disease after allogeneic hematopoietic cell transplant, Leuk Lymphoma, 51, 376, 10.3109/10428190903586318 Mackay, 2003, BAFF and APRIL: a tutorial on B cell survival, Annu Rev Immunol, 21, 231, 10.1146/annurev.immunol.21.120601.141152 Batten, 2000, BAFF mediates survival of peripheral immature B lymphocytes, J Exp Med, 192, 1453, 10.1084/jem.192.10.1453 Karnell, 2012, The interplay of IL-21 and BAFF in the formation and maintenance of human B cell memory, Front Immunol, 3, 2, 10.3389/fimmu.2012.00002 Fukui, 2007, Prevention of graft-versus-host disease by intra-bone marrow injection of donor T cells, Stem Cells, 25, 1595, 10.1634/stemcells.2006-0234 Lai Kwan Lam, 2008, Local BAFF gene silencing suppresses Th17-cell generation and ameliorates autoimmune arthritis, Proc Natl Acad Sci U S A, 105, 14993, 10.1073/pnas.0806044105 Shi, 2011, Combination of intra-bone marrow-bone marrow transplantation and subcutaneous donor splenocyte injection diminishes risk of graft-versus-host disease and enhances survival rate, Stem Cells Dev, 20, 759, 10.1089/scd.2010.0232 Simard, 2011, Analysis of the role of IL-21 in development of murine B cell progenitors in the bone marrow, J Immunol, 186, 5244, 10.4049/jimmunol.1004040 Tortola, 2010, IL-21 induces death of marginal zone B cells during chronic inflammation, Blood, 116, 5200, 10.1182/blood-2010-05-284547 Mackay, 2006, The role of the BAFF/APRIL system on T cell function, Semin Immunol, 18, 284, 10.1016/j.smim.2006.04.005 Bossen, 2006, BAFF, APRIL and their receptors: structure, function and signaling, Semin Immunol, 18, 263, 10.1016/j.smim.2006.04.006 Vallabhapurapu, 2008, Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-kappaB signaling, Nat Immunol, 9, 1364, 10.1038/ni.1678 Gardam, 2008, TRAF2 and TRAF3 signal adapters act cooperatively to control the maturation and survival signals delivered to B cells by the BAFF receptor, Immunity, 28, 391, 10.1016/j.immuni.2008.01.009 Yu, 2011, Prevention of GVHD while sparing GVL effect by targeting Th1 and Th17 transcription factor T-bet and RORgammat in mice, Blood, 118, 5011, 10.1182/blood-2011-03-340315 Yi, 2009, Reciprocal differentiation and tissue-specific pathogenesis of Th1, Th2, and Th17 cells in graft-versus-host disease, Blood, 114, 3101, 10.1182/blood-2009-05-219402 Rowe, 2006, Host B cells produce IL-10 following TBI and attenuate acute GVHD after allogeneic bone marrow transplantation, Blood, 108, 905, 10.1182/blood-2006-04-016063 Matte-Martone, 2010, Recipient B cells are not required for graft-versus-host disease induction, Biol Blood Marrow Transplant, 16, 1222, 10.1016/j.bbmt.2010.03.015 Kleindienst, 2005, Concerted antigen presentation by dendritic cells and B cells is necessary for optimal CD4 T-cell immunity in vivo, Immunology, 115, 556, 10.1111/j.1365-2567.2005.02196.x von Bergwelt-Baildon, 2002, Human primary and memory cytotoxic T lymphocyte responses are efficiently induced by means of CD40-activated B cells as antigen-presenting cells: potential for clinical application, Blood, 99, 3319, 10.1182/blood.V99.9.3319 Knoechel, 2005, The link between lymphocyte deficiency and autoimmunity: roles of endogenous T and B lymphocytes in tolerance, J Immunol, 175, 21, 10.4049/jimmunol.175.1.21 Allen, 2012, B cells from patients with chronic GVHD are activated and primed for survival via BAFF-mediated pathways, Blood, 120, 2529, 10.1182/blood-2012-06-438911 Sarantopoulos, 2007, High levels of B-cell activating factor in patients with active chronic graft-versus-host disease, Clin Cancer Res, 13, 6107, 10.1158/1078-0432.CCR-07-1290 Mackay, 2009, Cracking the BAFF code, Nat Rev Immunol, 9, 491, 10.1038/nri2572 Costanzo, 2010, IL-21 in the pathogenesis and treatment of skin diseases, J Dermatol Sci, 60, 61, 10.1016/j.jdermsci.2010.08.016 Ye, 2004, BAFF binding to T cell-expressed BAFF-R costimulates T cell proliferation and alloresponses, Eur J Immunol, 34, 2750, 10.1002/eji.200425198 Lee, 2013, Requirement for Rictor in homeostasis and function of mature B lymphoid cells, Blood, 122, 2369, 10.1182/blood-2013-01-477505